子宮筋腫治療装置市場レポート：2030年までの動向、予測、競合分析

子宮筋腫治療装置の動向と予測

世界の子宮筋腫治療装置市場は、2024年から2030年までのCAGRが8.4%で、2030年までに推定88億米ドルに達すると予測されています。この市場の主な促進要因は、子宮筋腫患者数の増加と、子宮筋腫を治療するための低侵襲的・非侵襲的処置に対する需要の増加です。世界の子宮筋腫治療装置市場の将来は、侵襲的、低侵襲的、非侵襲的な市場に機会があり、有望と思われます。

• Lucintel社は、子宮摘出術と筋腫摘出術の処置件数が増加していることから、予測期間中、外科的手術がより大きなセグメントであり続けると予測しています。
• この市場では、女性の子宮筋腫とその関連症状の件数増加により、侵襲的手術が引き続き最大セグメントとなります。
• 北米は、確立された医療施設の存在と同地域における政府のイニシアチブの高まりにより、予測期間中も最大セグメントであり続けると思われます。

よくある質問

Q1.市場規模は：

A1.世界の子宮筋腫治療装置市場は、2030年までに推定88億米ドルに達すると予想されています。

Q2.市場の成長予測は：

A2.世界の子宮筋腫治療装置市場は、2024年から2030年にかけてCAGR 8.4%で成長する見込みです。

Q3.市場の成長に影響を与える主な促進要因は：

A3.この市場の主な促進要因は、子宮筋腫患者数の増加と、子宮筋腫を治療するための低侵襲的・非侵襲的処置に対する需要の増加です。

Q4.市場の主要セグメントは：

A4.子宮筋腫治療装置市場の将来は、侵襲的、低侵襲的、非侵襲的な市場に機会があり、有望と思われます。

Q5.市場の主要企業は：

A5.主要な子宮筋腫治療装置企業は以下の通りです：

• Medtronic
• Stryker
• CooperSurgical
• Ethicon
• Hologic
• Minerva Surgical
• Lumenis

Q6.今後、最大となる市場セグメントは：

A6.Lucintelは、子宮摘出術や筋腫摘出術の手術件数が増加していることから、予測期間中、外科手術がより大きなセグメントであり続けると予測しています。

Q7.市場において、今後5年間に最大になると予想される地域は：

A7.北米は確立された医療施設が存在し、政府のイニシアチブが高まっているため、予測期間中も最大セグメントであり続けます。

Q8.レポートのカスタマイズは可能か：

A8.はい、Lucintelは追加費用なしで10％のカスタマイズを提供します。

目次

第1章 エグゼクティブサマリー

第2章 世界の子宮筋腫治療装置市場：市場力学

• イントロダクション、背景、分類
• サプライチェーン
• 業界の促進要因と課題

第3章 2018年から2030年までの市場動向と予測分析

• マクロ経済動向（2018～2023年）と予測（2024～2030年）
• 世界の子宮筋腫治療装置市場の動向（2018～2023年）と予測（2024～2030年）
• 技術別の子宮筋腫治療装置の世界市場
  • 外科手術
  • アブレーション
• 治療モード別の世界の子宮筋腫治療装置市場
  • 侵襲的
  • 低侵襲的
  • 非侵襲的

第4章 2018年から2030年までの地域別市場動向と予測分析

• 地域別子宮筋腫治療装置の世界市場
• 北米子宮筋腫治療装置市場
• 欧州の子宮筋腫治療装置市場
• アジア太平洋地域の子宮筋腫治療装置市場
• その他地域子宮筋腫治療装置市場

第5章 競合分析

• 製品ポートフォリオ分析
• 運用統合
• ポーターのファイブフォース分析

第6章 成長機会と戦略分析

• 成長機会分析
  • 技術別世界の子宮筋腫治療装置市場の成長機会
  • 治療モード別世界の子宮筋腫治療装置市場の成長機会
  • 地域別世界子宮筋腫治療装置市場の成長機会
• 世界の子宮筋腫治療装置市場の新たな動向
• 戦略分析
  • 新製品開発
  • 世界の子宮筋腫治療装置市場の能力拡大
  • 世界の子宮筋腫治療装置市場における合併、買収、合弁事業
  • 認証とライセンシング

第7章 主要企業の企業プロファイル

• Medtronic
• Stryker
• CooperSurgical
• Ethicon
• Hologic
• Minerva Surgical
• Lumenis

Uterine Fibroid Treatment Device Trends and Forecast

The future of the global uterine fibroid treatment device market looks promising with opportunities in the invasive, minimally invasive, and non-invasive markets. The global uterine fibroid treatment device market is expected to reach an estimated $8.8 billion by 2030 with a CAGR of 8.4% from 2024 to 2030. The major drivers for this market are growing number of uterine fibroid patients and increasing demand for minimally invasive and non-invasive procedures to treat uterine fibroids.

• Lucintel forecasts that surgical will remain the larger segment over the forecast period due to rising number of hysterectomy and myomectomy surgical procedures.
• Within this market, invasive will remain the largest segment due to rising cases of uterine fibroids and associated symptoms in women.
• North America will remain the largest segment over the forecast period due to existence of well-established healthcare facilities and growing government initiatives in the region.

Emerging Trends in the Uterine Fibroid Treatment Device Market

The Uterine Fibroid Treatment Device market also portrays some of the emergent trends resultant of continuous technological advancement and changing patient preference. These are bound to reshape the market in terms of better treatment options and accessibility.

• Minimally Invasive Techniques: Treatments that are minimally invasive, like MRgFUS and endometrial ablation, are increasingly being adopted. The recovery time is less, and the discomfort caused will also be lower, hence increasing their demand and, consequently, bringing about improvements
• Imaging Modalities Incorporated: Advanced imaging modalities such as MRI and ultrasound have been incorporated to have more precise treatment. These newer trends allow for better visualization of the fibroid and targeting with much more accuracy during the procedure.
• Comfort to the Patient: The design of devices is now being put in place with patient comfort in mind. This includes innovative designs that offer superior ergonomics and take less time, thus contributing a lot to an enhanced overall experience and satisfaction on the part of the patient.
• Affordable treatments: Realization of emerging markets calls for cheaper treatment options. Inexpensive devices by the manufacturers keep efficacy intact, making treatments highly affordable for a greater pool of people.
• Increased Research and Development: There is continuous R&D activity to develop more effective and safe devices for the treatment of uterine fibroids. Development involves new materials and technologies with better treatment outcomes and minimization of adverse effects.

These trends thereby mark a revolution in the treatment devices for uterine fibroids by facilitating better treatment options, enhanced patient experience, and accessibility to therapies with cost-effectiveness.

Recent Developments in the Uterine Fibroid Treatment Device Market

Following recent developments in the market for uterine fibroid treatment devices, some interesting insights related to technological advancement and market extension can be portrayed. Such changes form an influential impact on treatment practices and results for patients.

• Advancement of MRgFUS Technology: The second and third generations of MRI-guided focused ultrasound treatment devices have improved the accuracy and efficacy of the procedure. The new devices are offering non-invasive treatments with high-quality imaging, ensuring better patient outcomes.
• Introduction of New Radiofrequency Devices: New radiofrequency ablation treatment devices have been introduced in the market. These new devices are effectively treating uterine fibroids with shorter recovery times. Since these devices are minimally invasive, they are gaining wide acceptance due to the favorable clinical outcomes.
• Local Manufacturing Expansion: The number of local manufacturing for uterine fibroid treatment devices is growing in the emerging markets of the world, like China and India, where the costs are lower. This, in turn, does lead to heightened accessibility and affordability of treatments, especially in resource-poor regions.
• Integration with Imaging: Advanced integration of imaging technologies with treatment devices has improved accuracy in targeting fibroids and treatment planning. Innovations in imaging techniques result in more effective and personalized treatment options.
• Introduction of Low-Cost Alternatives: With the entry of a few new, low-cost alternatives, the market, especially in developing economies, has become more amenable. Low-cost options are attempting to make the treatment for uterine fibroids more inclusive for a greater and larger pool of patients.

All these factors are driving the growth of the Uterine Fibroid Treatment Device market by enhancing the efficacy, access, and affordability of the procedure.

Strategic Growth Opportunities for Uterine Fibroid Treatment Device Market

The Uterine Fibroid Treatment Device market has several applications that indicate strategic opportunities for growth. These are indicative of emerging patient needs and technological evolution.

• Increasing Adoption of Minimally Invasive Options: This is one of the major trends observed in the entry of minimally invasive treatment options, particularly to address the demand from a rise in patients' needs. Some techniques, like MRgFUS and endometrial ablation, are in more demand than others currently due to their lower recovery times and effectiveness.
• Integration of Advanced Imaging: There is quite a scope of advanced imaging technologies' integration into the treatment devices themselves. Further, enhanced imaging would facilitate a more accurate treatment planning system and help in yielding better treatment outcomes for patients.
• Development of Affordable Devices: The development of cost-effective treatment devices is an important growth opportunity for the emerging markets. Making treatments more affordable and accessible can tap large patient populations, a factor that would actually drive the market to expand.
• Comforting Innovations: Design ergonomics and reduction in procedure time are some of the opportunities that ensure further growth. Improvement in patient comfort may also lead to greater adoption and satisfaction.
• Partnerships: Strategic partnerships with local manufacturers and healthcare providers will increase the market share. Collaboration might provide access to new markets and better distribution.

These emerging opportunities for growth are influencing the use of innovation, better access improvement in patient care in the Uterine Fibroid Treatment Device market.

Uterine Fibroid Treatment Device Market Driver and Challenges

Technological, economic, and regulatory elements of various kinds shape up the drivers and challenges that influence the Uterine Fibroid Treatment Device market. Understanding these elements becomes important to navigate the market with efficacy.

The factors responsible for driving the uterine fibroid treatment device market include:

1. Rising Demand for Minimally Invasive Treatments: This factor is driving the growth of the market. Associated with very minimal recovery time and discomfort, these devices are increasingly being preferred by patients and healthcare providers.

2. Increased Awareness and Diagnosis Rates: Due to increasing awareness and diagnostic tools, there is more detection of uterine fibroids. So the increasing incidence has created an interesting demand for effective treatment options. Moreover, this demand opens up more opportunities for the growth of the market.

3. Cost-Effective Solution: Cost-effective devices are targeted towards developing price-sensitive markets. Cost-effective solutions have created affordability and increased the adoption rate in emerging regions.

4. Improved Research and Development: The design and development of numerous advanced treatment devices have continuously involved the R&D activity. Technology advancements and creation of new products are expanding the options for treatment.

Challenges in the uterine fibroid treatment device market are:

1. Regulatory Hurdles: Complex regulatory environments can be difficult to work with. Stricter regulations and prolonged approval processes may result in delayed entry into the market and at an increased cost for the manufacturers.

2. High Production Costs: The high expenses of development and manufacturing of advanced treatment devices check market growth. In the light of these, the reduction of production costs and enhancement of cost efficiency are required for wider market adoption.

3. Market Competition: Intense competition among manufacturers affects market share and pricing. The companies need to differentiate their products with innovation and quality to stay competitive.

These drivers and challenges are shaping the landscape of the Uterine Fibroid Treatment Device market through technological development, market dynamics, and regulations. Addressing these factors will, in turn, enable stakeholders to realize more opportunities for growth with higher simplicity in the market.

List of Uterine Fibroid Treatment Device Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. Through these strategies uterine fibroid treatment device companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the uterine fibroid treatment device companies profiled in this report include-

• Medtronic
• Stryker
• CooperSurgical
• Ethicon
• Hologic
• Minerva Surgical
• Lumenis

Uterine Fibroid Treatment Device by Segment

The study includes a forecast for the global uterine fibroid treatment device by technology, mode of treatment, and region.

Uterine Fibroid Treatment Device Market by Technology [Analysis by Value from 2018 to 2030]:

• Surgical
• Ablation

Uterine Fibroid Treatment Device Market by Mode of Treatment [Analysis by Value from 2018 to 2030]:

• Invasive
• Minimally Invasive
• Non-Invasive

Uterine Fibroid Treatment Device Market by Region [Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

Country Wise Outlook for the Uterine Fibroid Treatment Device Market

The Uterine Fibroid Treatment Device market has been changing very fast due to increasing rates of technological improvements and demand for non-invasive treatments. Current developments across the United States, China, Germany, India, and Japan reflect a trend of increasing efficacy and comfort for the patient in the management of uterine fibroids.

• United States: Innovations in minimally invasive procedures within the US market include MRI-guided focused ultrasound and new radiofrequency devices, enhancing the precision of treatments and outcomes for patients. Approvals by regulatory bodies are boosting further adoptions.
• China: There is a growing emphasis on augmenting the availability of uterine fibroid treatment devices through local manufacturing in China. Recent local developments include the introduction of affordable options for addressing the large patient base and improving access to treatments in rural areas.
• Germany: Companies operating in Germany stress advanced imaging technologies combined in a treatment device for uterine fibroids. Other innovations are in developing new imaging techniques that enhance the pre-treatment planning of a procedure and the precision thereof. Others have even begun clinical trials that are necessary to confirm efficacy for new devices.
• India: The Indian uterine fibroids treatment market is witnessing the acquisition of more accessibly-priced, effective treatment options. Recent developments include the launch of devices in the market at affordable prices and intensifying efforts towards educating and training healthcare professionals.
• Japan: Japan is proceeding with modern technologies of uterine fibroid treatment, including new laser systems and automated devices. Such technologies are innovative in order to enhance treatment efficiency and provide patient safety with great emphasis on accuracy with minimal side effects.

Features of the Global Uterine Fibroid Treatment Device Market

Market Size Estimates: Uterine fibroid treatment device market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Uterine fibroid treatment device market size by technology, mode of treatment, and region in terms of value ($B).

Regional Analysis: Uterine fibroid treatment device market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different technologies, mode of treatment, and regions for the uterine fibroid treatment device market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the uterine fibroid treatment device market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

If you are looking to expand your business in this market or adjacent markets, then contact us. We have done hundreds of strategic consulting projects in market entry, opportunity screening, due diligence, supply chain analysis, M & A, and more.

FAQ

Q1. What is the uterine fibroid treatment device market size?

Answer: The global uterine fibroid treatment device market is expected to reach an estimated $8.8 billion by 2030.

Q2. What is the growth forecast for uterine fibroid treatment device market?

Answer: The global uterine fibroid treatment device market is expected to grow with a CAGR of 8.4% from 2024 to 2030.

Q3. What are the major drivers influencing the growth of the uterine fibroid treatment device market?

Answer: The major drivers for this market are growing number of uterine fibroid patients and increasing demand for minimally invasive and non-invasive procedures to treat uterine fibroids.

Q4. What are the major segments for uterine fibroid treatment device market?

Answer: The future of the uterine fibroid treatment device market looks promising with opportunities in the invasive, minimally invasive, and non-invasive markets.

Q5. Who are the key uterine fibroid treatment device market companies?

Answer: Some of the key uterine fibroid treatment device companies are as follows:

• Medtronic
• Stryker
• CooperSurgical
• Ethicon
• Hologic
• Minerva Surgical
• Lumenis

Q6. Which uterine fibroid treatment device market segment will be the largest in future?

Answer: Lucintel forecasts that surgical will remain the larger segment over the forecast period due to rising number of hysterectomy and myomectomy surgical procedures.

Q7. In uterine fibroid treatment device market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest segment over the forecast period due to existence of well-established healthcare facilities and growing government initiatives in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the uterine fibroid treatment device market by technology (surgical and ablation), mode of treatment (invasive, minimally invasive, and non-invasive), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?
• Market Report

Table of Contents

1. Executive Summary

2. Global Uterine Fibroid Treatment Device Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

• 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
• 3.2. Global Uterine Fibroid Treatment Device Market Trends (2018-2023) and Forecast (2024-2030)
• 3.3: Global Uterine Fibroid Treatment Device Market by Technology
  • 3.3.1: Surgical
  • 3.3.2: Ablation
• 3.4: Global Uterine Fibroid Treatment Device Market by Mode of Treatment
  • 3.4.1: Invasive
  • 3.4.2: Minimally Invasive
  • 3.4.3: Non-Invasive

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

• 4.1: Global Uterine Fibroid Treatment Device Market by Region
• 4.2: North American Uterine Fibroid Treatment Device Market
  • 4.2.1: North American Uterine Fibroid Treatment Device Market by Technology: Surgical and Ablation
  • 4.2.2: North American Uterine Fibroid Treatment Device Market by Mode of Treatment: Invasive, Minimally Invasive, and Non-Invasive
• 4.3: European Uterine Fibroid Treatment Device Market
  • 4.3.1: European Uterine Fibroid Treatment Device Market by Technology: Surgical and Ablation
  • 4.3.2: European Uterine Fibroid Treatment Device Market by Mode of Treatment: Invasive, Minimally Invasive, and Non-Invasive
• 4.4: APAC Uterine Fibroid Treatment Device Market
  • 4.4.1: APAC Uterine Fibroid Treatment Device Market by Technology: Surgical and Ablation
  • 4.4.2: APAC Uterine Fibroid Treatment Device Market by Mode of Treatment: Invasive, Minimally Invasive, and Non-Invasive
• 4.5: ROW Uterine Fibroid Treatment Device Market
  • 4.5.1: ROW Uterine Fibroid Treatment Device Market by Technology: Surgical and Ablation
  • 4.5.2: ROW Uterine Fibroid Treatment Device Market by Mode of Treatment: Invasive, Minimally Invasive, and Non-Invasive

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Uterine Fibroid Treatment Device Market by Technology
  • 6.1.2: Growth Opportunities for the Global Uterine Fibroid Treatment Device Market by Mode of Treatment
  • 6.1.3: Growth Opportunities for the Global Uterine Fibroid Treatment Device Market by Region
• 6.2: Emerging Trends in the Global Uterine Fibroid Treatment Device Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Uterine Fibroid Treatment Device Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Uterine Fibroid Treatment Device Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: Medtronic
• 7.2: Stryker
• 7.3: CooperSurgical
• 7.4: Ethicon
• 7.5: Hologic
• 7.6: Minerva Surgical
• 7.7: Lumenis